Docusate Sodium

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Docusate Sodium
Generic name: DOCUSATE SODIUM
Manufacturer: American Health Packaging
Product type: HUMAN OTC DRUG
SPL set ID: be7cab51-ce7e-465d-95db-083e69288cfd
SPL ID: 5516c65f-7c50-a154-e063-6394a90a0181
Version: 9
Effective date: 2026-06-25
Source export date: 2026-10-12
Source partition: 7
Source file: https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/ff22b88bd32e56cbc369af80345075227138a42b1b3ba9a84f038fd5493a7a47/drug-label-0007-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 01:59:20

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 13 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M007	openfda.application_number
brand name		Docusate Sodium	openfda.brand_name
generic name		DOCUSATE SODIUM	openfda.generic_name
manufacturer name		American Health Packaging	openfda.manufacturer_name
ndc	package	60687-129-11	openfda.package_ndc
ndc	package	60687-129-01	openfda.package_ndc
ndc	product	60687-129	openfda.product_ndc
ndc11	package	60687012901	derived:openfda.package_ndc
ndc11	package	60687012911	derived:openfda.package_ndc
rxcui		1115005	openfda.rxcui
spl id		5516c65f-7c50-a154-e063-6394a90a0181	id
spl set id		be7cab51-ce7e-465d-95db-083e69288cfd	set_id
unii		F05Q2T2JA0	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Do not use if you are currently taking mineral oil, unless directed by a doctor when abdominal pain, nausea or vomiting are present unless directed by a doctor for longer than one week unless directed by a doctor Ask a doctor before use if you notice a sudden change in bowel habits that persists over a period of 2 weeks. Stop use and ask a doctor if you have rectal bleeding or you fail to have a bowel movement after use of a laxative. This may indicate a serious condition. If pregnant or breast-feeding, ask a health care professional before use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.